Concepts (179)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myocytes, Cardiac | 13 | 2024 | 618 | 2.520 |
Why?
|
| Fibroblasts | 10 | 2024 | 878 | 1.860 |
Why?
|
| Cellular Reprogramming | 7 | 2024 | 116 | 1.790 |
Why?
|
| Myocardial Infarction | 7 | 2023 | 994 | 1.460 |
Why?
|
| GATA4 Transcription Factor | 5 | 2024 | 40 | 1.400 |
Why?
|
| Cell Transdifferentiation | 5 | 2021 | 67 | 1.220 |
Why?
|
| Cellular Reprogramming Techniques | 4 | 2020 | 22 | 0.990 |
Why?
|
| T-Box Domain Proteins | 5 | 2022 | 117 | 0.880 |
Why?
|
| Vascular Endothelial Growth Factor A | 3 | 2016 | 413 | 0.850 |
Why?
|
| Endothelium | 1 | 2021 | 73 | 0.760 |
Why?
|
| Heart Diseases | 2 | 2023 | 479 | 0.620 |
Why?
|
| Gene Transfer Techniques | 3 | 2016 | 374 | 0.610 |
Why?
|
| Rats | 11 | 2024 | 3654 | 0.610 |
Why?
|
| Fibrosis | 2 | 2017 | 428 | 0.590 |
Why?
|
| Regeneration | 2 | 2017 | 202 | 0.590 |
Why?
|
| Myogenic Regulatory Factors | 2 | 2014 | 16 | 0.570 |
Why?
|
| Lentivirus | 1 | 2017 | 84 | 0.560 |
Why?
|
| Transcription Factors | 5 | 2024 | 2579 | 0.440 |
Why?
|
| Heart | 1 | 2017 | 723 | 0.410 |
Why?
|
| Cell Differentiation | 2 | 2024 | 1934 | 0.410 |
Why?
|
| MEF2 Transcription Factors | 4 | 2017 | 33 | 0.400 |
Why?
|
| Ventricular Function | 1 | 2012 | 93 | 0.400 |
Why?
|
| Neovascularization, Physiologic | 1 | 2012 | 209 | 0.380 |
Why?
|
| Genetic Vectors | 4 | 2017 | 970 | 0.330 |
Why?
|
| Coronary Artery Bypass | 3 | 2001 | 486 | 0.310 |
Why?
|
| Animals | 17 | 2024 | 33724 | 0.280 |
Why?
|
| Endothelial Cells | 2 | 2021 | 527 | 0.260 |
Why?
|
| Myocardium | 5 | 2024 | 981 | 0.240 |
Why?
|
| Rats, Inbred F344 | 2 | 2014 | 106 | 0.220 |
Why?
|
| Technology | 1 | 2023 | 64 | 0.210 |
Why?
|
| Flow Cytometry | 3 | 2021 | 809 | 0.210 |
Why?
|
| Adenoviridae | 2 | 2016 | 637 | 0.200 |
Why?
|
| Cell Plasticity | 1 | 2021 | 32 | 0.190 |
Why?
|
| Coculture Techniques | 1 | 2021 | 235 | 0.190 |
Why?
|
| Cell Separation | 1 | 2021 | 237 | 0.180 |
Why?
|
| Butyric Acid | 1 | 2020 | 7 | 0.180 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 2020 | 39 | 0.180 |
Why?
|
| Heart Arrest, Induced | 1 | 2000 | 73 | 0.180 |
Why?
|
| Pyrimidinones | 1 | 2020 | 40 | 0.170 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2020 | 75 | 0.170 |
Why?
|
| Tretinoin | 1 | 2020 | 117 | 0.170 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2020 | 78 | 0.170 |
Why?
|
| Hemodynamics | 2 | 2000 | 839 | 0.170 |
Why?
|
| Myocardial Contraction | 1 | 2000 | 261 | 0.160 |
Why?
|
| Intraoperative Complications | 1 | 2000 | 174 | 0.160 |
Why?
|
| Animals, Newborn | 1 | 2021 | 1007 | 0.150 |
Why?
|
| Snail Family Transcription Factors | 1 | 2017 | 24 | 0.150 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2017 | 19 | 0.150 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2020 | 1213 | 0.140 |
Why?
|
| Gene Silencing | 1 | 2018 | 236 | 0.140 |
Why?
|
| Fibronectins | 1 | 2017 | 104 | 0.140 |
Why?
|
| Trans-Activators | 2 | 2018 | 805 | 0.140 |
Why?
|
| Collagen Type I | 1 | 2017 | 110 | 0.140 |
Why?
|
| Zinc Fingers | 1 | 2017 | 113 | 0.140 |
Why?
|
| Sp1 Transcription Factor | 1 | 2016 | 43 | 0.140 |
Why?
|
| Phosphoproteins | 1 | 2018 | 400 | 0.130 |
Why?
|
| Prevalence | 1 | 2021 | 2366 | 0.120 |
Why?
|
| Down-Regulation | 1 | 2017 | 701 | 0.120 |
Why?
|
| Leukemia | 1 | 2017 | 375 | 0.110 |
Why?
|
| DNA-Binding Proteins | 2 | 2024 | 2028 | 0.110 |
Why?
|
| Histones | 1 | 2017 | 530 | 0.110 |
Why?
|
| Tissue Engineering | 2 | 2005 | 176 | 0.110 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2017 | 541 | 0.110 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2012 | 461 | 0.100 |
Why?
|
| Models, Animal | 1 | 2014 | 465 | 0.100 |
Why?
|
| Blotting, Western | 1 | 2014 | 1104 | 0.100 |
Why?
|
| Humans | 20 | 2024 | 122120 | 0.100 |
Why?
|
| Heart-Assist Devices | 1 | 2000 | 1022 | 0.100 |
Why?
|
| Disease Models, Animal | 2 | 2016 | 4288 | 0.090 |
Why?
|
| Heart Transplantation | 2 | 1996 | 853 | 0.090 |
Why?
|
| Blood Flow Velocity | 2 | 1989 | 448 | 0.090 |
Why?
|
| Male | 16 | 2020 | 59429 | 0.090 |
Why?
|
| Aorta | 2 | 1998 | 534 | 0.090 |
Why?
|
| Transfection | 1 | 2012 | 1076 | 0.090 |
Why?
|
| Aortic Valve | 2 | 1992 | 426 | 0.090 |
Why?
|
| Bioprosthesis | 2 | 1993 | 111 | 0.090 |
Why?
|
| Signal Transduction | 2 | 2024 | 4511 | 0.090 |
Why?
|
| MicroRNAs | 1 | 2016 | 838 | 0.080 |
Why?
|
| Echocardiography | 2 | 2012 | 1066 | 0.080 |
Why?
|
| Drug Therapy, Combination | 1 | 2012 | 1145 | 0.080 |
Why?
|
| Arteriosclerosis | 1 | 1989 | 139 | 0.080 |
Why?
|
| Rheology | 1 | 1988 | 31 | 0.080 |
Why?
|
| Heart Valve Prosthesis | 3 | 1993 | 293 | 0.080 |
Why?
|
| Extracellular Matrix | 2 | 2005 | 230 | 0.070 |
Why?
|
| Aortic Diseases | 1 | 1989 | 197 | 0.070 |
Why?
|
| Epigenesis, Genetic | 2 | 2022 | 665 | 0.060 |
Why?
|
| Homeobox Protein Nkx-2.5 | 1 | 2024 | 16 | 0.060 |
Why?
|
| Multipotent Stem Cells | 1 | 2024 | 29 | 0.060 |
Why?
|
| Prostheses and Implants | 1 | 2005 | 151 | 0.060 |
Why?
|
| Mice | 4 | 2024 | 17552 | 0.060 |
Why?
|
| Cells, Cultured | 2 | 2020 | 3074 | 0.050 |
Why?
|
| Aged | 9 | 2001 | 18735 | 0.050 |
Why?
|
| Alginates | 1 | 2020 | 18 | 0.050 |
Why?
|
| RNA, Small Interfering | 1 | 2022 | 663 | 0.040 |
Why?
|
| Diastole | 1 | 2000 | 170 | 0.040 |
Why?
|
| Anastomosis, Surgical | 1 | 2000 | 169 | 0.040 |
Why?
|
| Ventricular Function, Right | 1 | 2000 | 111 | 0.040 |
Why?
|
| Aortic Valve Insufficiency | 2 | 1992 | 138 | 0.040 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2001 | 342 | 0.040 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2000 | 193 | 0.040 |
Why?
|
| Middle Aged | 7 | 2001 | 25538 | 0.040 |
Why?
|
| Wnt Signaling Pathway | 1 | 2020 | 199 | 0.040 |
Why?
|
| Swine | 2 | 2016 | 1157 | 0.040 |
Why?
|
| Stroke Volume | 1 | 2000 | 446 | 0.040 |
Why?
|
| Female | 13 | 2005 | 64764 | 0.040 |
Why?
|
| Coronary Disease | 1 | 2001 | 630 | 0.040 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2017 | 64 | 0.040 |
Why?
|
| Ventricular Function, Left | 1 | 2000 | 500 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2012 | 12020 | 0.030 |
Why?
|
| Subclavian Vein | 1 | 1996 | 23 | 0.030 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2005 | 1099 | 0.030 |
Why?
|
| Troponin T | 1 | 2018 | 245 | 0.030 |
Why?
|
| New Zealand | 1 | 1996 | 49 | 0.030 |
Why?
|
| Subclavian Artery | 1 | 1996 | 71 | 0.030 |
Why?
|
| Arteriovenous Fistula | 1 | 1996 | 56 | 0.030 |
Why?
|
| Aneurysm | 1 | 1996 | 89 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 2016 | 968 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2000 | 1300 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2022 | 1521 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2016 | 379 | 0.030 |
Why?
|
| Waiting Lists | 1 | 1996 | 220 | 0.030 |
Why?
|
| Cause of Death | 1 | 1996 | 453 | 0.030 |
Why?
|
| Tricuspid Valve | 1 | 1993 | 61 | 0.030 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 1993 | 63 | 0.030 |
Why?
|
| Thrombosis | 1 | 1998 | 515 | 0.030 |
Why?
|
| Heart Failure | 1 | 2005 | 2125 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2017 | 2441 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2020 | 2535 | 0.020 |
Why?
|
| Survival Rate | 1 | 1996 | 1997 | 0.020 |
Why?
|
| Phenotype | 1 | 2020 | 4151 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2016 | 1277 | 0.020 |
Why?
|
| Myosins | 1 | 1990 | 46 | 0.020 |
Why?
|
| Leiomyosarcoma | 1 | 1990 | 30 | 0.020 |
Why?
|
| Abdominal Neoplasms | 1 | 1990 | 33 | 0.020 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 1998 | 648 | 0.020 |
Why?
|
| Mediastinal Neoplasms | 1 | 1990 | 41 | 0.020 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 1998 | 784 | 0.020 |
Why?
|
| Mathematics | 1 | 1988 | 97 | 0.020 |
Why?
|
| Adult | 5 | 2001 | 28676 | 0.020 |
Why?
|
| Aortic Valve Stenosis | 1 | 1992 | 322 | 0.020 |
Why?
|
| Heart Block | 1 | 1987 | 41 | 0.020 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 1987 | 112 | 0.020 |
Why?
|
| Graft Rejection | 1 | 1990 | 578 | 0.020 |
Why?
|
| Risk Factors | 2 | 2001 | 9864 | 0.020 |
Why?
|
| Time Factors | 1 | 1996 | 6168 | 0.020 |
Why?
|
| Absorbable Implants | 1 | 2005 | 24 | 0.020 |
Why?
|
| Materials Testing | 1 | 2005 | 73 | 0.020 |
Why?
|
| Esophageal Neoplasms | 1 | 1990 | 355 | 0.020 |
Why?
|
| Sus scrofa | 1 | 2005 | 121 | 0.020 |
Why?
|
| Polytetrafluoroethylene | 1 | 2005 | 80 | 0.020 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2005 | 58 | 0.020 |
Why?
|
| Biocompatible Materials | 1 | 2005 | 123 | 0.020 |
Why?
|
| Urinary Bladder | 1 | 2005 | 241 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 2005 | 417 | 0.010 |
Why?
|
| Wound Healing | 1 | 2005 | 454 | 0.010 |
Why?
|
| Coronary Vessels | 1 | 2005 | 525 | 0.010 |
Why?
|
| Heart Ventricles | 1 | 2005 | 767 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2001 | 6291 | 0.010 |
Why?
|
| Pericardial Effusion | 1 | 1998 | 64 | 0.010 |
Why?
|
| Angiography, Digital Subtraction | 1 | 1996 | 51 | 0.010 |
Why?
|
| Biomarkers | 1 | 2005 | 2939 | 0.010 |
Why?
|
| Endocarditis, Bacterial | 1 | 1992 | 129 | 0.010 |
Why?
|
| Calcinosis | 1 | 1992 | 167 | 0.010 |
Why?
|
| Heart Valve Diseases | 1 | 1992 | 167 | 0.010 |
Why?
|
| Abdominal Muscles | 1 | 1990 | 27 | 0.010 |
Why?
|
| Macaca | 1 | 1990 | 61 | 0.010 |
Why?
|
| Necrosis | 1 | 1990 | 212 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2001 | 2997 | 0.010 |
Why?
|
| Random Allocation | 1 | 1990 | 415 | 0.010 |
Why?
|
| Graft Survival | 1 | 1990 | 522 | 0.000 |
Why?
|
| Sick Sinus Syndrome | 1 | 1987 | 12 | 0.000 |
Why?
|
| Tachycardia, Supraventricular | 1 | 1987 | 105 | 0.000 |
Why?
|
| Heart Arrest | 1 | 1990 | 341 | 0.000 |
Why?
|
| Adolescent | 2 | 1993 | 18929 | 0.000 |
Why?
|
| Age Factors | 1 | 1987 | 2774 | 0.000 |
Why?
|
| Child | 2 | 1993 | 24049 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 1987 | 8096 | 0.000 |
Why?
|
| Infant | 1 | 1987 | 12304 | 0.000 |
Why?
|
| Child, Preschool | 1 | 1987 | 13781 | 0.000 |
Why?
|